RxION | Evidence-Based Weight Loss & Pain Relief Treatments
Choose from 4 proven treatments: Semaglutide, Tirzepatide, LDN for weight loss, or LDN for chronic pain.
Weight Loss & Pain Relief That Actually Works
Stop cycling through treatments that don't work. Our evidence-based medications address the root cause.
4 proven treatments → Find what works for your specific condition
Licensed providers → Real doctors, not wellness coaches
Evidence-based approach → Published research, not marketing hype
Transparent pricing → No hidden fees, HSA/FSA eligible
Tirzepatide (Mounjaro/Zepbound) for Weight Loss | RxION
Next-generation Tirzepatide for superior weight loss. 22.5% average weight reduction.
Tirzepatide: The Dual-Action Weight Loss Revolution
The newest, most powerful GLP-1/GIP receptor agonist. Up to 22.5% average weight loss in clinical trials.
What makes Tirzepatide different from Semaglutide?
Tirzepatide targets both GLP-1 and GIP receptors (dual-action), while Semaglutide only targets GLP-1.
This dual mechanism results in superior weight loss—47% greater weight loss than Semaglutide.
How much weight can I expect to lose?
In clinical trials, Tirzepatide users lost an average of 20-22.5% of their body weight.
What are the side effects?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and decreased appetite.
Does insurance cover Tirzepatide?
Insurance coverage varies. Our program offers competitive cash pricing at $399-649/month.
How long do I need to take Tirzepatide?
Tirzepatide is typically a long-term treatment. Most patients continue as long as they're seeing benefits.
Semaglutide (Ozempic/Wegovy) for Weight Loss | RxION
FDA-approved Semaglutide for medical weight loss. 15-20% average weight reduction.
Semaglutide: The Original GLP-1 That Changed Everything
The gold standard of medical weight loss. Average weight loss: 15% of body weight in clinical trials.
FDA-approved for weight management since 2021
Once-weekly injection with proven results
15-20% average body weight reduction
Cardiovascular benefits documented in SUSTAIN trials
LDN for Weight Loss | Low-Dose Naltrexone Treatment - RxION
Evidence-based LDN treatment for weight management. Reduces food noise, normalizes appetite.
When Food Noise Never Stops, There's Finally a Volume Control
Low-Dose Naltrexone modulates endorphin pathways and reduces neuroinflammation.
Endorphin reset lasting 18-24 hours → Wake up without planning breakfast
TNF-α, IL-6, IL-1β reduction → Your metabolism starts cooperating again
Gradual sustainable weight loss → No crash diets, no rebound
Effective for PCOS, fibromyalgia, autoimmune → Finally, something designed for you
LDN for Chronic Pain Relief | Low-Dose Naltrexone Treatment - RxION
Evidence-based LDN treatment for chronic pain. 65% response rate in fibromyalgia, CRPS.
Your Pain Isn't 'All in Your Head'—It's Neuroinflammation Running Wild
Clinical research shows LDN modulates microglial activation in 65% of chronic pain patients.
TLR4 antagonism reduces TNF-α, IL-6, IL-1β → Pain signals stop screaming
Endorphin surge lasting 18-24 hours → Your body's natural pain relief, activated
65% response rate in fibromyalgia studies → Better odds than you've had before
No addiction, no tolerance, no withdrawal → Safe for long-term pain management